Larson Financial Group’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-207	Closed	-$1.36K	–	2864
2024 Q3	$1.36K	Sell	207 -101	-33%	-$666	﹤0.01%	1906
2024 Q2	$2.31K	Buy	308 +199	+183%	+$1.49K	﹤0.01%	1570
2024 Q1	$1.09K	Buy	+109	New	+$1.09K	﹤0.01%	1433